Ms Terri Simzer, DPT in Lisbon, NY - Physical Therapist

Ms Terri Simzer, DPT is a Physical Therapist based in Lisbon, New York. Ms Terri Simzer is licensed to practice in New York (license number 020877-1) and her current practice location is 125 Keyes Rd, Lisbon, New York. She can be reached at her office (for appointments etc.) via phone at (315) 393-2606.

NPI number for Ms Terri Simzer is 1922203850 and her current mailing address is 125 Keyes Rd, Lisbon, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1922203850.

Contact Information

	Ms Terri Simzer, DPT
	125 Keyes Rd, Lisbon, NY 13658-3204
	(315) 393-2606
	Not Available

Healthcare Provider's Profile

Full Name	Ms Terri Simzer
Gender	Female
Speciality	Physical Therapist
Location	125 Keyes Rd, Lisbon, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1922203850
Provider Enumeration Date: 06/20/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Ms Terri Simzer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922203850	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	020877-1 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Terri Simzer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Terri Simzer, DPT 125 Keyes Rd, Lisbon, NY 13658-3204 Ph: (315) 393-2606	Ms Terri Simzer, DPT 125 Keyes Rd, Lisbon, NY 13658-3204 Ph: (315) 393-2606

News Archive

Caffeine and acetaminophen don't mix well

Consuming large amounts of caffeine while taking acetaminophen, one of the most widely used painkillers in the United States, could potentially cause liver damage, according to a preliminary laboratory study reported in the Oct. 15 print issue of ACS' Chemical Research in Toxicology, a monthly journal.

Research opens up new exploration possibilities for Alzheimer's disease

Researchers at Universitat Aut-noma de Barcelona (UAB) and University of Stockholm have created a computer modelling of the structural malfunctioning of the ApoE4 protein when it enters into contact with the Amyloid beta molecule, the main cause of Alzheimer's disease.

Washington University receives award to develop diagnostic tools for heart, lung diseases using nanotechnology

An $18 million research program headed by Washington University School of Medicine in St. Louis will research therapies and diagnostic tools for heart and lung diseases that use nanotechnology.

Scientists discover novel therapeutic target and treatment strategy for acute myeloid leukemia

University of Hawai'i Cancer Center researchers discovered a novel therapeutic target and treatment strategy for acute myeloid leukemia, a cancer of the blood and bone marrow that normally requires prompt and aggressive treatment.

Researchers identify 125 genetic components in temozolomide-resistant, GBM-derived cell line

University of Pittsburgh Cancer Institute (UPCI) researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line, which could offer new hope for drug treatment to destroy the cancer cells.

Ms Terri Simzer, DPT - Physical Therapist in Lisbon, NY